salt forms of semaglutide FDA Warns on Certain Compounded PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Incretin therapies used for weight management include GLP-1 RAs (ie, dulaglutide, liraglutide, semaglutide) and dual agonists of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors (ie, tirzepatide)

However, your provider should review your complete medication profile to ensure combination safety, particularly if you're on additional serotonergic agents

If you are mapping peptide categories, cagrilintide belongs with amylin analogues, while semaglutide belongs with GLP-1 receptor agonists and tirzepatide belongs with GIP/GLP-1 dual agonists

The most commonly prescribed options include GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), which are FDA-approved specifically for chronic weight management

Additionally, disrupted sleep throws off your hunger (ghrelin) and satiety (leptin) hormones, which then causes increased feelings of hunger, leading to higher calorie intake

Contact a healthcare professional if you have repeated lows, persistent vomiting, chest pain, fainting, shortness of breath, confusion, or symptoms that do not improve with rest and fluids